February 19th, 2010
Podcast 75: Which regimen for hypertension?
Podcast: Play in new window | Download
Subscribe: RSS
Patients with hypertension at risk for cardiovascular events have done better with an ACE inhibitor-calcium channel blocker combination than with the ACE inhibitor plus hydrochlorothiazide. The ACCOMPLISH investigators have now reported on their analysis of progression-of-nephropathy outcomes in their trial. We interview the first author of the analysis, Dr. George Bakris of the University of Chicago’s Pritzker School of Medicine.
Interview-related links:
News-related links: